Academic Journal
Q2Clinical and Experimental Rheumatology
About Clinical and Experimental Rheumatology
About Clinical and Experimental Rheumatology
Clinical and Experimental Rheumatology is a peer-reviewed scholarly journal published by Clinical and Experimental Rheumatology S.A.S. (Italy). It focuses on Q2. Publication coverage spans 1983-2026.
Key indicators: ISSN 0392-856X, 1593-098X; H-index 114.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (114): Exceptionally high — 114 articles have each been cited at least 114 times. This indicates deep, sustained influence in the field.
Publishing in Clinical and Experimental Rheumatology
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q2. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Clinical and Experimental Rheumatology?
0392-856X, 1593-098X.
Who publishes Clinical and Experimental Rheumatology?
Clinical and Experimental Rheumatology S.A.S..
What are Clinical and Experimental Rheumatology's metrics?
H-index 114.
Where do I submit to Clinical and Experimental Rheumatology?
Via the official website.
Is Clinical and Experimental Rheumatology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Rheumatoid Arthritis Research and Therapies; Spondyloarthritis Studies and Treatments; Systemic Sclerosis and Related Diseases; Systemic Lupus Erythematosus Research; Inflammatory Myopathies and Dermatomyositis; Vasculitis and related conditions.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Atypical variants in COL1A1 and COL3A1 associated with classical and vascular Ehlers-Danlos syndrome overlap phenotypes: expanding the clinical phenotype based on additional case reports
Marlies Colman, Marco Castori, Lucia Micale, Marco Ritelli et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/kzkq6yOff-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases
Matilde Bandeira, Ana Vieira, Vera Guimarães, Tatiana Bento et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/v1e7s2Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients
Imane Abouyahya, Sophie I.E. Liem, Zahir Amoura, João Eurico Fonseca et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/x5arasAssociation of common variable immunodeficiency and rare and complex connective tissue and musculoskeletal diseases. A systematic literature review
Johanna Mucke, Alain Cornet, Torsten Witte, Matthias Schneider et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/bbuvihEfficacy of intravenous immunoglobulin in shrinking lung syndrome associated with mixed connective tissue disease: a case report
Manuel Silvério-António, Nikita Khmelinskii, João Eurico Fonseca
2022-05-18 · DOI: 10.55563/clinexprheumatol/aotrf1Sjögren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison
Chiara Baldini, Laurent Arnaud, Tadej Avčin, Lorenzo Beretta et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/3y0hqsBlood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners
Luca Iaccarino, Rosaria Talarico, Emanuele Bozzalla-Cassione, Gerd R. Burmester et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/qq9qupHoarseness as the presentation of immunoglobulin G4-related disease with vocal cord and mediastinal infiltration
Eduardo Dourado, Ana Silva Martins, João Eurico Fonseca
2022-05-18 · DOI: 10.55563/clinexprheumatol/nk7khlGender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres
Liala Moschetti, Luisa Dal Pozzolo, Veronique Le Guern, Nathalie Morel et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/9royriRheumatology residency in a European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases centre: opportunities and challenges
Eduardo Dourado, Ana Teresa Melo, Giovanni Pacini, Anne Pankow et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/2s2c31Rarities in rare: illuminating the microvascular and dermal status in juvenile localised scleroderma. A case series
Amber Vanhaecke, Dieneke Schonenberg-Meinema, Sofie De Schepper, Sandy C. Bergkamp et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/2vm1pzTreatment of relapsing polychondritis: a systematic review
Arthur Petitdemange, Cédric Sztejkowski, Laura Damian, Thierry Martin et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/h9gq1oCapillary leak syndrome in a patient with cancer-associated anti-transcriptional intermediary factor 1γ dermatomyositis treated with rituximab
Bianca Lucia Palermo, Francesca Bottazzi, Eduardo Dourado, Veronica Codullo et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/j26b6oRare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation
Chiara Tani, Elena Elefante, Laurent Arnaud, Sofia C. Barreira et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/jrz47cThe added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET
Rosaria Talarico, Silvia Aguilera, Tobias Alexander, Zahir Amoura et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/d2qz38Respiratory failure due to concomitant interstitial lung disease and diaphragmatic involvement in a patient with anti-MDA5 dermatomyositis: a case report
Silvia Grignaschi, Silvia Mongodi, Enrico Alfonsi, Francesco Mojoli et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/0u7vdcRare within rare. Necrotising scleritis and peripheral ulcerative keratitis: eye-threatening complications of relapsing polychondritis
Laura Damian, Cristina Pamfil, Camelia Bucșa, Cristina Nicula et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/27n7imAnti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study
Emanuele Bozzalla-Cassione, Giovanni Zanframundo, Alessandro Biglia, Elisa Bellis et al.
2022-05-18 · DOI: 10.55563/clinexprheumatol/bjb2gfEffects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease
Magdalena Benad, Dirk Koschel, Kristine Herrmann, Kristin Wiefel et al.
2022-03-23 · DOI: 10.55563/clinexprheumatol/o5t1f7Value of contrast-enhanced ultrasonography in assessing the activity of idiopathic retroperitoneal fibrosis: a prospective study
Jian Shang, Mengdan Liu, Yiwen Wang, Yu An et al.
2022-03-22 · DOI: 10.55563/clinexprheumatol/qie29jReviews
Community Reviews
Version History
October 9, 2026 at 9:01 pm
October 2, 2026